Are you Dr. Rosenblum?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 92 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1275 York Avenue
New York, NY 10065
Summary
- Dr. Marc Rosenblum, MD is a board certified pathologist in New York, New York. He is currently licensed to practice medicine in New York and New Jersey. He is affiliated with Memorial Sloan Kettering Cancer Center, New York-Presbyterian Hospital, and NYC Health + Hospitals / Bellevue.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1983 - 1986
Icahn School of Medicine at Mount Sinai (Mount Sinai Hospital)Residency, Pathology-Anatomic and Clinical, 1979 - 1983
University of Miami Leonard M. Miller School of MedicineClass of 1979
Certifications & Licensure
NY State Medical License 1980 - 2026
NJ State Medical License 2006 - 2025- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2008-2014
- America's Top Doctors Castle Connolly, 2008-2014
- Top Doctors: New York Metro Area Castle Connolly, 2008-2014
- Join now to see all
Publications & Presentations
PubMed
- Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions.Joanna Cyrta, Josephine K Dermawan, Arnault Tauziède-Espariat, Ting Liu, Marc Rosenblum
The Journal of Pathology. 2024-11-01 - 1 citationsA Comprehensive Clinicopathologic and Molecular Reappraisal of GLI1 -altered Mesenchymal Tumors with Pooled Outcome Analysis Showing Poor Survival in GLI1 - amplified ...Carla Saoud, Abbas Agaimy, Josephine K Dermawan, Jie-Fu Chen, Marc K Rosenblum
The American Journal of Surgical Pathology. 2024-10-01 - Mechanism of neurodegeneration mediated by clonal inflammatory microglia.Rocio Vicario, Stamatina Fragkogianni, Maria Pokrovskii, Carina Mayer, Estibaliz Lopez-Rodrigo
Biorxiv. 2024-07-31
Press Mentions
Sloan Kettering’s Cozy Deal with Start-up Ignites a New UproarSeptember 20th, 2018
